Top Markets
Coin of the day
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Classement en actions #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Prix de l'action
$3.92
Dernière synchronisation: 2025-08-14
Capitalisation boursière
$2.34M
Changement (1 jour)
-69.38%
Changement (1 an)
0.00%
Pays
US
Échange ReShape Lifesciences Inc. (RSLS)

Catégorie

Le prix RSLS avec la capitalisation boursière de B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Capitalisation boursière de ReShape Lifesciences Inc.(RSLS)
Capitalisation boursière: $2.34M
En August 2026, ReShape Lifesciences Inc. a une capitalisation boursière de $2.34M. Cela fait de ReShape Lifesciences Inc. la 36770th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ReShape Lifesciences Inc. du 2019 au 2026
RSLS par rapport au top 5 des plus populaires stocks
Prix pour RSLS L’actif B La capitalisation boursière de B Résultats
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
$2.833T +121,156,629.05%